Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 2017-06, Vol.38 (22), p.1710
Hauptverfasser:	Niessner, Alexander, Tamargo, Juan, Morais, João, Koller, Lorenz, Wassmann, Sven, Husted, Steen Elkjær, Torp-Pedersen, Christian, Kjeldsen, Keld, Lewis, Basil S, Drexel, Heinz, Kaski, Juan Carlos, Atar, Dan, Storey, Robert F, Lip, Gregory Y H, Verheugt, Freek W A, Agewall, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Antibodies, Monoclonal, Humanized - therapeutic use Anticoagulants - administration & dosage Antidotes - therapeutic use Arginine - administration & dosage Arginine - analogs & derivatives Consensus Dabigatran - antagonists & inhibitors Evidence-Based Medicine Factor Xa - administration & dosage Forecasting Hemorrhage - chemically induced Humans Medicin och hälsovetenskap Piperazines - administration & dosage Recombinant Proteins - administration & dosage Risk Factors Thrombosis - drug therapy Vitamin K - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!